This study established a simultaneous screening method based on solid-phase extraction and liquid chromatography-tandem mass spectrometry (LC-MS-MS) for the detection of 23 stimulants and 23 diuretics in human urine. An electrospray ionization source and multiple reaction monitoring were used for data acquisition. All stimulants and diuretics were separated in less than 12.52 min. The limits of detection were in the range of 25-500 ng/mL for stimulants and 25-125 ng/mL for diuretics. To evaluate the performance of this method, urine samples were collected from 1627 athletes in Taiwan, and 7 positive samples were found. This LC-MS-MS method not only meets the minimum required performance limits set by the World Anti-Doping Agency but also provides a fast way to analyze the authentic urine samples in doping control laboratories.
Introduction
Stimulants can promote exercise performance by stimulating the central nervous system and improving energy metabolism (1, 2) ; on the other hand, diuretics can increase urine elimination, reduce weight, and affect results of drug detection (3). Therefore, both stimulants and diuretics are prohibited for athletes by the World Anti-Doping Agency (WADA) (4) . However, a high percentage of positive results for stimulants and diuretics in athletes are often reported by WADAaccredited laboratories (5). For example, the Review Board of the National Olympic Committee (NOC) showed a high rate of stimulants and diuretics use in Taiwanese athletes (unpublished data).
Detection of stimulants or diuretics in human urine has been performed by high-performance liquid chromatography (HPLC) (6,7), gas chromatography-mass spectrometry (GC-MS) (8) (9) (10) , and liquid chromatography-tandem mass spectrometry (LC-MS-MS) (11) (12) (13) (14) . GC-MS can be used to screen the polar and non-volatile compounds; therefore, it has been employed extensively in doping analysis. However, the problem with this technique is that it is difficult to detect compounds that have different chemical properties using different derivative agents. Recently, the simultaneous detection of WADA-prohibited substances by LC-MS-MS has been demonstrated (15) (16) (17) . Because derivatization is not necessary for sample preparation in LC-MS-MS methods, these methods allow direct detection of compounds with additional structure information. Therefore, LC-MS-MS is playing an increasingly important role in doping analysis.
The list of the banned stimulants and diuretics has grown from 2003 to 2008 according to WADA report (5, [18] [19] [20] [21] [22] . In order to reduce the number of separate analytical procedures, decrease workloads, and facilitate reporting, a method for simultaneous screening of stimulants and diuretics is necessary. For example, the simultaneous detection of stimulants and diuretics has been reported by Kolmonen et al. (15) and Mazzarino et al. (23) . However, the number of stimulants and diuretics screened by both groups is much fewer than that listed by WADA. Therefore, the aim of this study was to develop a novel simultaneous screening method based on LC-MS-MS to detect as many stimulants and diuretics as possible. The method was further applied to authentic urines collected in Taiwan to verify its performance. purchased from Sigma-Aldrich (St. Louis, MO). Amphetamine, benzoylecgonine, cathine, ephedrine, methylamphetamine, 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxyethylamphetamine (MDEA), methylenedioxymethamphetamine (MDMA), methylenedioxymethamphetamine-d 5 (MDMA-d 5 ), and methylephedrine were purchased from Cerilliant (Round Rock, TX). Canrenone, dichlorphenamide, hydroxyamphetamine hydrobromide, and polythiazide were purchased from USP (Rockville, MD). Metolazone was purchased from Wako (St. Montague, CA). Piretanide and torasemide were purchased from EP Scientific (Miami, OK). Sibutramine was purchased from LKT (St. Paul, MN).
Methanol and isopropanol were purchased from Mallinckrodt Baker (Phillipsburg, NJ). Methylene chloride was purchased from J.T. Baker (St. Louis, MO). Potassium phosphate monobasic, 25% ammonium hydroxide, 37% hydrochloric acid, and formic acid were purchased from Sigma-Aldrich. Sodium potassium was purchased from Showa (Tokyo, Japan). Doubly deionized water was obtained from a Millipore Direct-Q5 system (Bedford, MA) and used throughout this study.
Figure 1 (continued).
Extracted ion chromatogram of a blank urine spiked with stimulants at 500 ng/mL, strychnine at 200 ng/mL, and diuretics at 250 ng/mL.
Standard solutions were prepared at 1 mg/mL in methanol. The working solutions were prepared by successive dilutions of standard solutions to concentrations from 1 to 50 µg/mL. All solutions were stored at -20°C in the dark. Solid-phase extraction (SPE) columns (CEC SPE-DOA 100 mg/3 mL) were obtained from Chrom Expert (Sacramento, CA).
Instrument
An Agilent 1200 series LC system with binary gradient pumps and an automatic injector (Agilent Technologies SpA, Cernuscosul Naviglio, Italy) was interfaced with an Applied Biosystems API3000 (Applera Europe B.V., Monza, Italy) triplequadrupole MS with both positive and negative electrospray ionization capabilities. A Supelco Discovery ♦ HS-C 18 HPLC column (50 mm × 2.1-mm i.d., 3-µm particle size, Bellefonte, PA) and a Supelco Discovery HS-C 18 guard column (20 mm × 2.1-mm i.d., 3-µm particle size) were used.
LC-MS-MS
A two-solvent linear gradient was used for chromatographic separation. Chromatography was accomplished using 0.2% formic acid in deionized water (solvent A) and 0.2% formic acid in methanol (solvent B). Both solvents were filtered through a 0.45-µm membrane and then degassed before use. The samples were analyzed by two separated injections. A linear gradient of positive mode was run at 0% B, increased to 95% B from 0 min to 9 min, decreased to 0% B from 9 min to 9.5 min, and reequilibrated at 0% B for 7.5 min. The total running time of the positive mode was 17 min, and the flow rate was 0.25 mL/min. A linear gradient of negative mode was run at 0% B, increased to 75% B from 0 to 3 min, flushed for 6 min at 75% B, then decreased to 0% B from 9 to 9.5 min, and finally re-equilibrated at 0% B for 6.5 min. The total running time was 16 min, and the flow rate of 0.25 mL/min was increased to 0.35 mL/min from 0 to 3 min, decreased to 0.1 mL/min from 3 to 9 min, increased again to 0.25 mL/min from 9 to 9.5 min, and finally reequilibrated at 0.25 mL/min for 6.5 min.
The turbo gas temperature was 450°C, and the auxiliary gas flow was 8.0 L/min. Nebulizing gas, curtain gas, and collision gas flows were at instrument settings of 13, 7, and 12, respectively. The IonSpray voltage was set at 5500V in the positive mode and -4500V in the negative mode. The MS was operated in the multiple reaction monitoring (MRM) acquisition mode with both quadrupoles maintained at unit resolution. In order to improve the sensitivity of this method, data acquisition was divided into three segments based on the analytes expected retention time.
Sample preparation
Urine samples collected from 1627 Taiwanese athletes were centrifuged for 10 min at 14,000 × g, and the clear upper layer of liquid (1.0 mL) was taken. Twenty microliters of internal standard (IS) MDMA-d 5 (10 µg/mL) and 0.5 mL phosphate buffer (0.1 M, pH 6.0) were added and mixed. Samples were then poured into SPE columns that had been preconditioned with methanol (1.0 mL) and phosphate buffer (1.0 mL). The cartridge was washed with HCl (0.5 mL, 0.01 M) and eluted with 1.5 mL methanol and 2.0 mL of elution solvent (70% dichloromethane, 28% isopropanol, 2% ammonium hydroxide). The elution solvent was dried under nitrogen at 40°C. The dried residue was reconstituted in 300 µL of solvent A and filtered through a 0.45-µm syringe. Finally, a 5-µL aliquot was injected onto the instrument.
Method validation
LOD was defined as the lowest level of concentration at which a compound could be identified in all urines tested with the lowest transition selected with a signal-to-noise ratio of ≥ 3.
The recoveries of all target compounds tested in urine by SPE were determined at the minimum required performance limits (MRPL, 500 ng/mL for stimulants, 200 ng/mL for strychnine, and 250 ng/mL for diuretics) regulated by WADA (24) . Nine drug-free urine samples were fortified at the MRPL concentration with all of the compounds tested, another nine drug-free urine specimens were extracted according to the described SPE protocol, and all compounds tested were added to the elution solvent evaporation. Twenty microliters of the IS was added to the elution solvents of the both sets of samples before evaporation. Recovery was evaluated by comparing the mean peak-area ratio of the analyte and the IS in samples fortified prior to and after SPE.
The repeatability was estimated by the percent CV in the relative retention times (RRT) of the analytes and the ion ratios of the characteristic transitions at the WADA MRPL concentration. Selectivity was validated by analyzing nine different urine specimens prepared as described by the SPE protocol.
Identification criteria for qualitative assays
The criteria for identification of a compound follow the criteria of WADA technical document (TD 2003IDCR) (25) .
Results and Discussions
The purpose of this study was to develop a qualitative LC-MS-MS method for simultaneous detection of stimulants and diuretics in urine specimens from doping analyses. Extracted ion chromatograms of stimulants and diuretics are displayed in Figure 1 . The retention times of all compounds were less than 12.52 min. Declustering potential (DP), focusing potential (FP), collision energy (CE), collision cell exit potential (CXP), and MRM transitions are listed in Table I. Table II summarizes the parameters for the method validation, including retention time, LOD, recovery, and repeatability. The relative retention time and the ion ratio were below 10% and 15% of CV values for all target compounds, respectively. The LOD concentrations were in the range of 25-500 ng/mL. Recoveries ranged from 26.5% to 116%, and the %CV values were below 15 for all compounds. The reproducibility by analyzing the different urine matrix fortified at the MRPL concentration once a day for three months. No variation in the RRT value was observed. The selectivity experiments showed no significant interferences at the expected retention times of the target compounds. Carryover was assessed by injecting drug-free urine samples after high-concentration standards, and no signals were found. The overall performance of the method in this study was validated.
Several methods for screening prohibited anti-doping substances have been proposed. For example, Kolmonen et al. (15) used an expensive and time-consuming LC-time-of-flight MS method to detect diuretics, stimulants, anabolic steroids, narcotics, anti-estrogenic drugs, and beta-adrenergic agents. Mazzarino et al. (23) used an LC-triple-quadrupole MS method to detect glucocorticoids, diuretics, stimulants, anti-estrogens, beta-adrenergic drugs, and anabolic steroids. The screening numbers of stimulants and diuretics are 10 and 21, respectively. Because the positive usage rate of stimulants and diuretics are higher in WADA's report (5, [18] [19] [20] [21] [22] , as well as in Taiwan's report (unpublished data), it is necessary to develop a qualitative method for the simultaneous detection of stimulants and diuretics in order to decrease workloads and expenses of each test. Our result showed that 23 stimulants and 23 diuretics can be simultaneously detected using LC-MS-MS, which is more efficient than the previous studies.
There are 64 stimulants listed by WADA. However, only 23 stimulants were screened by our method. The other stimulants were not identified in this study because of the unavailability of these reference standards and substances in Taiwan. Fifteen prohibited substances are on the list of diuretics class (4). Our methods showed that 22 diuretics can be detected which are more than the number listed by WADA. Diuretics, benzthiazide, benzylhydrochlorothiazide, dichlorphenamide, methazolamide, piretanide, polythiazide, and torasemide, can also be effectively screened by LC-MS-MS. The screening procedures focused on the direct detection of the unchanged diuretics and probenicid, one of the masking agents (4). Because the major metabolite of spironolactone is canrenone, spironolactone was replaced by canrenone for identification.
The measurement uncertainty of the quantitative results of those threshold substances (ephedrines) were evaluated by the quantitative method. The chromatographic method was performed with LC-MS-MS. The turbo gas temperature was 450°C, and the auxiliary gas flow was 8.0 L/min. Nebulizing gas, curtain gas, and collision gas flows were at instrument settings of 13, 7, and 12, respectively. The IonSpray voltage was set at 5500V in the positive mode. The MS was operated in MRM acquisition mode. A two-solvent linear gradient was accomplished using 0.2% formic acid in deionized water (solvent A) and 0.2% formic acid in methanol (solvent B). A linear gradient of positive mode was run at 0% B, increasing to 5% B from 0 min to 8 min, decreasing to 0% B from 8 min to 8.5 min, and re-equilibrated at 0% B for 31.5 min. The total running time was 40 min and the flow rate was 0.2 mL/min. Ten microliters internal standard ephedrine-d 3 (10 µg/mL), 0.2 mL urine sample, and 0.6 mL deionized water were added and mixed. The mixture was centrifuged for 10 min at 14,000 × g, and the clear upper layer liquid was taken. The clear upper layer liquid was filtered through 0.45-µm syringe. Finally, a 10-µL aliquot was injected onto the instrument.
A total of 1627 samples were collected from Taiwanese athletes who were asked to provide at least 75 mL urine for doping control purpose in-competition and out-of-competition during 2008. The presence of furosemide (Figure 2A) , phentermine ( Figure 2B ), ephedrine ( Figure 2C ), mephetermine ( Figure  2D ), methylephedrine ( Figure 2E ), norephedrine ( Figure 2F ), and pseudoephedrine ( Figure 2G ) were found. Substances were all identified based on the retention times, characteristic ions and relative ion intensities, according to the criteria of a WADA technical document (TD2003IDCR) (25) . The retention time and characteristic ions in Figure 2 indicated no differences between the authentic urine samples and the standard solution of the mixture of stimulants and diuretics (Table II) . The results met the criteria for confirmation analysis in doping control.
Several urine specimens from athletes both in-competition and out-of-competition in Taiwan have shown positive results for mephentermine and/or phentermine. We have reported that oxethazine may be the source of mephentermine and phentermine (26) . Methylephedrine will metabolize to ephedrine first, and ephedrine then further metabolize to norephedrine (27) . Therefore, when an athlete ingested methylephedrine, ephedrine and norephedrine usually showed positive as well.
Conclusions
A novel LC-MS-MS method for simultaneously detecting 23 stimulants and 23 diuretics in human urine was developed. SPE was used to reduce the amount of urine needed for sample extraction. Based on the findings, the method proposed in this study has the advantages of decreased workload and cost and rapid sample preparation of a small urine volume requirement (1.0 mL). It is believed that this method can be successful and suitable for routine use in anti-doping laboratories.
